Bibliografía del artículo
1. Schurman L, Bagur A, Claus-Hemberg H y cols. Guías para diagnóstico, prevención y tratamiento de la osteoporosis 2007. Consenso de la Sociedad Argentina de Osteoporosis y la Asociación Argentina de Osteología y Metabolismo Mineral. Actualiz Osteol 2007; 3:117-136.
2. Favus MJ. Bisphosphonates for osteoporosis. N Eng J Med 2010; 363:2027-2035.
3. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000; 85:590-596.
4. Black DM, Cummings SR, Karpf DB y cols. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348:1535-1541.
5. Harris ST, Watts NB, Genant HJ y cols. Effects of risedronate treatment on vertebral and non vertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Group. J Am Med Assoc 1999: 282:1344-1352.
6. McClung MR, Bolognese MA, Sedarati F y cols. Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal osteoporosis. Bone 2009; 44:418-422.
7. Ensrud KE, Stock JL, Barrett-Connor E y cols. Effects of raloxifene on fracture risk in postmenopausal women: The Raloxifene Use for the Heart Trial. J Bone Mineral Res 2008; 23:112-120.
8. Roux C, Reginster JY, Fechtenbaum J y cols. Vertebral facture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Mineral Res 2006; 21:536-542.
9. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313:973-975.
10. Bjarnason NH, Nielsen TF, Jørgensen HL, Christiansen C. The influence of smoking on bone loss and response to nasal estradiol. Climacteric 2009; 12:59-65
11. Camarelles Guillem F, Salvador Llivina T, Ramón Torell JM y cols. Consenso sobre la atención sanitaria del tabaquismo en España. Rev Esp Salud Pública 2009; 83:175-200.